Todd Rosengart, MD

Dr. Todd K. Rosengart, Baylor Tıp Fakültesi'nde (BCM) Michael E. DeBakey Cerrahi Bölümü Profesörü ve Başkanıdır. Aynı zamanda DeBakey-Bard Cerrahi Kürsüsü'nü de yürütmektedir ve Texas Kalp Enstitüsü Profesyonel Personeli'nin bir ortağıdır.

Tüm biyografiyi göster

Dr. Rosengart, BCM ve Texas Üniversitesi öğretim üyelerinin HarrisHealth ilçe tıbbi sistemi için 1000 sağlayıcıdan oluşan bir tıbbi hizmetler konsorsiyumu olan Bağlı Tıbbi Hizmetler'in Yönetim Kurulu Başkanıdır, BCM Fakülte Grup Uygulaması'nın başkan yardımcısıdır ve 350 sağlayıcılı BCM özel birimini denetlemektedir. klinik fakülte grubudur ve Baylor St. Luke Tıp Merkezi'nin Ortak Girişim Kurulu'nda görev yapmaktadır.

Ayrıca yakın zamanda CHI Kardiyotorasik Cerrahi Klinik Standartlar Komitesi'nin Ulusal Başkanı olarak görev yaptı ve 20 üye hastanesi bulunan kar amacı gütmeyen ulusal bir kuruluş olan CHI'nin üyesi olarak kalp cerrahisi gerçekleştiren 120 kurumun kardiyovasküler cerrahi faaliyetlerini denetledi.

Houston'a gelmeden önce Dr. Rosengart, SUNY-Stony Brook'ta Profesör ve Cerrahi Bölümü Başkanı, Kalp ve Göğüs Cerrahisi Şefi ve Stony Brook Üniversitesi Kalp Merkezi'nin Eş Direktörü olarak görev yapıyordu. Daha önce Evanston Northwestern Healthcare'de Owen L. Coon Cerrahi Kürsüsü Başkanı ve Northwestern Üniversitesi'nde Cerrahi Profesörü olarak görev yaptı. Bundan önce Dr. Rosengart, Weill Cornell Tıp Fakültesi'nde Kardiyotorasik Cerrahi alanında Doçent ve New York Presbiteryen Hastanesi'nde Kardiyotorasik Cerrahi Uzmanı Doçenti idi. MD derecesini Northwestern Üniversitesi Tıp Eğitimi Onur Programından aldı. Genel cerrahi eğitimini New York Üniversitesi'nde, kalp-torasik cerrahi uzmanlığını ise The New York Hospital'da tamamladı. Aynı zamanda Ulusal Kalp, Akciğer ve Kan Enstitüsü Cerrahi Şubesinde Tıbbi Personel Üyesi olarak görev yaptı.

Dr. Rosengart'ın öncelikli araştırma konusu gen transferi ve yeni kan damarı gelişiminin (anjiyogenez) yanı sıra hücresel yeniden programlama alanıdır. 1997 yılında, kendisi ve Cornell'deki ekibi, NIH ve FDA onaylı ilk insan Faz I denemesinin bir parçası olan, dünyanın ilk viral bazlı kardiyak gen transfer prosedürünü gerçekleştirdi. Dr. Rosengart, 20 yılı aşkın bir süredir kesintisiz finansmanla NIH tarafından finanse edilen bir laboratuvarı yönetmeye devam ediyor ve araştırma ve diğer hibelerden yaklaşık 15 milyon dolar alıyor. On iki ABD patentine sahiptir ve 200 hakemli makalenin ve 9600'den fazla alıntının olduğu diğer yayınların yazarıdır ve h-indeksi 52'dir (Google Scholar).

Kurumsal ve araştırma görevlerine ek olarak, Dr. Rosengart şu anda NIH Biyomühendislik, Teknoloji ve Cerrahi Bilimler Çalışma Bölümü'nün başkanı, Amerikan Kalp Derneği Cerrahi Temel Bilim Çalışması Bölümü'nün başkanı ve Göğüs ve Kardiyovasküler Cerrahi Seminerleri Editörüdür. Cerrahi Başkanlar Derneği'nin Başkan Yardımcısı (seçilecek başkan), Güney Göğüs Cerrahisi Derneği Konsey Üyesi ve Amerikan Cerrahi Derneği'nin üyesidir. Amerikan Cerrahlar Koleji ve Amerikan Kardiyoloji Koleji'nin üyesidir ve Amerikan Göğüs Cerrahisi Derneği, Göğüs Cerrahisi Derneği, Güney Cerrahi Derneği ve Teksas Cerrahi Derneği'nin üyesidir. Aynı zamanda New York Cerrahi Derneği ve New York Göğüs Cerrahisi Derneği üyeliğine de sahiptir.

Seri girişimci olan Dr. Rosengart, ayda 15 milyondan fazla tekil ziyaretle dünyanın en büyük doktor arama ve tıbbi tüketim web sitelerinden biri olan Vitals.com'un (MDx, LLC) kurucu ortağıdır ve XyloCor Therapeutics'in kurucu ortağıdır. , son evre koroner arter hastalığı olan hastaların tedavisine yönelik yeni bir kardiyak gen terapisi prototipinin Faz I/II testi için "Fast Track" tanımıyla FDA onayına sahip bir gen terapisi girişimi.

Yayınlara Bakın

Teksas Kalp Enstitüsü Pozisyonları

İlgi

  • Minimal İnvaziv Kapak Cerrahisi
  • Koroner Arter Bypass Cerrahisi
  • Kalp ve Damar Cerrahisi
  • Gen transferi ve yeni kan damarı gelişimi (anjiyogenez)
  • Koroner arter hastalığı

Eğitim

  • Tıp Okulu:

    Northwestern Üniversitesi

  • Staj:

    New York Üniversitesi Tıp Merkezi

  • İkamet:

    New York Üniversitesi Tıp Merkezi

  • Burslar:

    New York Hastanesi (Kalp ve Damar Cerrahisi Bursu)
    Ulusal Sağlık Enstitüleri (Cerrahi Şubesi)

Akademik ve Klinik Bağlantılar

Başarılar, Ödüller ve Üyelikler

Yayınlar

4862227 BCTBZ4XB 1 hayvan deneylerine alternatifler 10 tarih Azalan Rosengart 2073 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22V9ABFX88%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ali%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAli%2C%20A.%2C%20Gray%2C%20Z.%2C%20Loor%2C%20G.%20et%20al.%20%282024%29.%20Minimally%20Invasive%20Mitral%20Valve%20Surgery%20Using%20a%20Cold%20Fibrillatory%20Cardiac%20Arrest%20Technique%20in%20Patients%20With%20Prior%20Cardiac%20Surgery.%20%26lt%3Bi%26gt%3BTexas%20Heart%20Institute%20Journal%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B51%26lt%3B%5C%2Fi%26gt%3B%2C%20e238167.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-23-8167%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-23-8167%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Minimally%20Invasive%20Mitral%20Valve%20Surgery%20Using%20a%20Cold%20Fibrillatory%20Cardiac%20Arrest%20Technique%20in%20Patients%20With%20Prior%20Cardiac%20Surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexis%20E.%22%2C%22lastName%22%3A%22Shafii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20K.%22%2C%22lastName%22%3A%22Liao%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Objective%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Minimally%20invasive%20mitral%20valve%20surgery%20%28mini-MVS%29%20is%20typically%20reserved%20for%20patients%20who%20have%20not%20undergone%20open%20cardiac%20surgery.%20In%20the%20reoperative%20setting%2C%20using%20intrapericardial%20dissection%20for%20crossclamping%20the%20aorta%20through%20a%20minimally%20invasive%20approach%20can%20be%20difficult%20and%2C%20at%20times%2C%20risky.%20Cold%20fibrillatory%20cardiac%20arrest%20%28CFCA%29%20with%20systemic%20cardiopulmonary%20bypass%20without%20cross-clamping%20is%20a%20well-described%20technique%3B%20however%2C%20data%20about%20its%20safety%20for%20patients%20who%20undergo%20reoperative%20mini-MVS%20are%20limited.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Data%20for%2034%20patients%20who%20underwent%20reoperative%20mini-MVS%20with%20CFCA%20from%20March%202017%20to%20March%202022%20were%20reviewed%20retrospectively.%20A%20mini%20right%20thoracotomy%20%28n%20%3D%2030%29%20or%20robotic%20%28n%20%3D%204%29%20approach%20was%20used.%20Systemic%20hypothermia%20was%20induced%20to%20a%20target%20temperature%20of%2025%20%5Cu00b0C.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Patient%20mean%20%28SD%29%20age%20was%2064.5%20%289.6%29%20years%2C%20and%2015%20of%2034%20%2844.1%25%29%20patients%20were%20women.%20Of%20those%2034%20patients%2C%2023%20%2867.6%25%29%20had%20severe%20regurgitation%2C%20and%2011%20%2832.4%25%29%20had%20severe%20stenosis.%20Before%20mini-MVS%2C%2028%20patients%20had%20undergone%20valve%20surgery%2C%20and%208%20had%20undergone%20coronary%20artery%20bypass%20graft%20surgery.%20The%20mitral%20valve%20was%20repaired%20in%205%20of%2034%20%2814.7%25%29%20and%20replaced%20in%2029%20of%2034%20%2885.3%25%29%20patients.%20No%20difference%20was%20observed%20in%20preoperative%20and%20postoperative%20left%20ventricular%20function%20%28%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20P%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3D%20.82%29.%20In%201%20patient%2C%20kidney%20failure%20developed%20that%20necessitated%20dialysis.%20No%20postoperative%20stroke%20or%20mortality%20at%2030%20days%20occurred.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusion%3A%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mini-MVS%20with%20CFCA%20is%20well%20tolerated%20in%20patients%20with%20prior%20cardiac%20surgery.%20Myocardial%20function%20was%20not%20impaired%2C%20nor%20was%20the%20risk%20of%20stroke%20increased%20in%20this%20cohort%2C%20indicating%20that%20CFCA%20is%20a%20safe%20alternative%20in%20this%20high-risk%20population.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-23-8167%22%2C%22ISSN%22%3A%221526-6702%2C%200730-2347%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fthij.kglmeridian.com%5C%2Fview%5C%2Fjournals%5C%2Fthij%5C%2F51%5C%2F2%5C%2Farticle-e238167.xml%22%2C%22collections%22%3A%5B%22BCTBZ4XB%22%5D%2C%22dateModified%22%3A%222025-02-06T23%3A12%3A25Z%22%7D%7D%2C%7B%22key%22%3A%226LEB44CZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brlecic%20et%20al.%22%2C%22parsedDate%22%3A%222023-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrlecic%2C%20P.%20E.%2C%20Whitlock%2C%20R.%20S.%2C%20Zhang%2C%20Q.%20et%20al.%20%282023%29.%20Dispersion%20of%20National%20Institute%20of%20Health%20funding%20to%20departments%20of%20surgery%20is%20contracting.%20%26lt%3Bi%26gt%3BJ%20Surg%20Res%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B289%26lt%3B%5C%2Fi%26gt%3B%2C%208%26%23x2013%3B15.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jss.2023.03.023%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jss.2023.03.023%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dispersion%20of%20National%20Institute%20of%20Health%20funding%20to%20departments%20of%20surgery%20is%20contracting%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paige%20E.%22%2C%22lastName%22%3A%22Brlecic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20S.%22%2C%22lastName%22%3A%22Whitlock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianzi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20A.%22%2C%22lastName%22%3A%22LeMaire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20NIH%20funding%20to%20departments%20of%20surgery%20reported%20as%20benchmark%20Blue%20Ridge%20Institute%20for%20Medical%20Research%20%28BRIMR%29%20rankings%20are%20unclear.%5CnMETHODS%3A%20We%20analyzed%20inflation-adjusted%20BRIMR-reported%20NIH%20funding%20to%20departments%20of%20surgery%20and%20medicine%20between%202011%20and%5Cu00a02021.%5CnRESULTS%3A%20NIH%20funding%20to%20departments%20of%20surgery%20and%20medicine%20both%20increased%2040%25%20from%202011%20to%202021%20%28%24325%20million%20to%20%24454%20million%3B%20%243.8%20billion%20to%20%245.3%20billion%2C%20P%5Cu00a0%26lt%3B%5Cu00a00.001%20for%20both%29.%20The%20number%20of%20BRIMR-ranked%20departments%20of%20surgery%20decreased%2014%25%20during%20this%20period%20while%20departments%20of%20medicine%20increased%205%25%20%2888%20to%2076%20versus%20111%20to%20116%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29.%20There%20was%20a%20greater%20increase%20in%20the%20total%20number%20of%20medicine%20PIs%20versus%20surgery%20PIs%20during%20this%20period%20%284377%20to%205224%20versus%20557%20to%20649%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29.%20These%20trends%20translated%20to%20further%20concentration%20of%20NIH-funded%20PIs%20in%20medicine%20versus%20surgery%20departments%20%2845%20PIs%5C%2Fprogram%20versus%208.5%20PIs%5C%2Fprogram%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29.%20NIH%20funding%20and%20PIs%5C%2Fprogram%20in%202021%20were%20respectively%2032%20and%2020%20times%20greater%20for%20the%20top%20versus%20lowest%2015%20BRIMR-ranked%20surgery%20departments%20%28%24244%20million%20versus%20%247.5%20million%20%5BP%5Cu00a0%26lt%3B%5Cu00a00.01%5D%3B%2020.5%20versus%201.3%20%5BP%5Cu00a0%26lt%3B%5Cu00a00.001%5D%29.%20Twelve%20%2880%25%29%20of%20the%20top%2015%20surgery%20departments%20maintained%20this%20ranking%20over%20the%2010-year%20study%20period.%5CnCONCLUSIONS%3A%20Although%20NIH%20funding%20to%20departments%20of%20surgery%20and%20medicine%20is%20growing%20at%20a%20similar%20rate%2C%20departments%20of%20medicine%20and%20top-funded%20surgery%20departments%20have%20greater%20funding%20and%20concentration%20of%20PIs%5C%2Fprogram%20versus%20surgery%20departments%20overall%20and%20lowest-funded%20surgery%20departments.%20Strategies%20used%20by%20top-performing%20departments%20to%20obtain%20and%20maintain%20funding%20may%20assist%20less%20well-funded%20departments%20in%20obtaining%20extramural%20research%20funding%2C%20thus%20broadening%20the%20access%20of%20surgeon-scientists%20to%20perform%20NIH-supported%20research.%22%2C%22date%22%3A%222023-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jss.2023.03.023%22%2C%22ISSN%22%3A%221095-8673%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BCTBZ4XB%22%2C%22EBAYDVV4%22%2C%225WVJH2TN%22%5D%2C%22dateModified%22%3A%222023-06-08T14%3A33%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22MVSV2XRA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sylvester%20et%20al.%22%2C%22parsedDate%22%3A%222023-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSylvester%2C%20C.%20B.%2C%20Ryan%2C%20C.%20T.%2C%20Frankel%2C%20W.%20C.%20et%20al.%20%282023%29.%20Readmissions%20after%20surgical%20aortic%20valve%20replacement%3A%20influence%20of%20prosthesis%20type.%20%26lt%3Bi%26gt%3BJ%20Surg%20Res%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B287%26lt%3B%5C%2Fi%26gt%3B%2C%20124%26%23x2013%3B133.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jss.2023.01.007%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jss.2023.01.007%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Readmissions%20after%20surgical%20aortic%20valve%20replacement%3A%20influence%20of%20prosthesis%20type%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20B.%22%2C%22lastName%22%3A%22Sylvester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20T.%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Frankel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%22%2C%22lastName%22%3A%22Zea-Vera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianzi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Wall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20R.%22%2C%22lastName%22%3A%22Moon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%20K.%22%2C%22lastName%22%3A%22Ghanta%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Prosthesis%20choice%20during%20aortic%20valve%20replacement%20%28AVR%29%20weighs%20lifelong%20anticoagulation%20with%20mechanical%20valves%20%28M-AVR%29%20against%20structural%20valve%20degeneration%20in%20bioprosthetic%20valves%20%28B-AVR%29.%5CnMETHODS%3A%20The%20Nationwide%20Readmissions%20Database%20was%20queried%20to%20identify%20patients%20who%20underwent%20isolated%20surgical%20AVR%20between%20January%201%2C%202016%20and%20December%2031%2C%202018%2C%20stratifying%20by%20prothesis%20type.%20Propensity%20score%20matching%20was%20used%20to%20compare%20risk-adjusted%20outcomes.%20Readmission%20at%201%5Cu00a0y%20was%20estimated%20with%20Kaplan-Meier%20%28KM%29%20analysis.%5CnRESULTS%3A%20Patients%20%28n%5Cu00a0%3D%5Cu00a0109%2C744%29%20who%20underwent%20AVR%20%2890%2C574%20B-AVR%20and%2019%2C170%20M-AVR%29%20were%20included.%20B-AVR%20patients%20were%20older%20%28median%2068%20versus%2057%5Cu00a0y%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29%20and%20had%20more%20comorbidities%20%28mean%20Elixhauser%20score%3A%2011.8%20versus%2010.7%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29%20compared%20to%20M-AVR%20patients.%20After%20matching%20%28n%5Cu00a0%3D%5Cu00a036%2C951%29%2C%20there%20was%20no%20difference%20in%20age%20%2858%20versus%2057%5Cu00a0y%3B%20P%5Cu00a0%3D%5Cu00a00.6%29%20and%20Elixhauser%20score%20%2811.0%20versus%2010.8%3B%20P%5Cu00a0%3D%5Cu00a00.3%29.%20B-AVR%20patients%20had%20similar%20in-hospital%20mortality%20%282.3%25%20versus%202.3%25%3B%20P%5Cu00a0%3D%5Cu00a00.9%29%20and%20cost%20%28mean%3A%20%2450%2C958%20versus%20%2451%2C200%3B%20P%5Cu00a0%3D%5Cu00a00.4%29%20compared%20with%20M-AVR%20patients.%20However%2C%20B-AVR%20patients%20had%20shorter%20length%20of%20stay%20%288.3%20versus%208.7%5Cu00a0d%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29%20and%20fewer%20readmissions%20at%2030%5Cu00a0d%20%2810.3%25%20versus%2012.6%25%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29%20and%2090%5Cu00a0d%20%2814.8%25%20versus%2017.8%25%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29%2C%20and%201%5Cu00a0y%20%28P%5Cu00a0%26lt%3B%5Cu00a00.001%2C%20KM%20analysis%29.%20Patients%20undergoing%20B-AVR%20were%20less%20likely%20to%20be%20readmitted%20for%20bleeding%20or%20coagulopathy%20%285.7%25%20versus%209.9%25%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29%20and%20effusions%20%289.1%25%20versus%2011.9%25%3B%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29.%5CnCONCLUSIONS%3A%20B-AVR%20patients%20had%20similar%20early%20outcomes%20compared%20to%20M-AVR%20patients%2C%20but%20lower%20rates%20of%20readmission.%20Bleeding%2C%20coagulopathy%2C%20and%20effusions%20are%20drivers%20of%20excess%20readmissions%20in%20M-AVR%20patients.%20Readmission%20reduction%20strategies%20targeting%20bleeding%20and%20improved%20anticoagulation%20management%20are%20warranted%20in%20the%20first%20year%20following%20AVR.%22%2C%22date%22%3A%222023-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jss.2023.01.007%22%2C%22ISSN%22%3A%221095-8673%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%22BCTBZ4XB%22%2C%22VCK5HVUS%22%2C%22AFDZBLNB%22%2C%22VKADJP5D%22%2C%22BNSCCUCI%22%5D%2C%22dateModified%22%3A%222023-06-08T14%3A14%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22LPN9ZURC%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brlecic%20et%20al.%22%2C%22parsedDate%22%3A%222023-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrlecic%2C%20P.%20E.%2C%20Bonham%2C%20C.%20A.%2C%20%26lt%3Bstrong%26gt%3BRosengart%26lt%3B%5C%2Fstrong%26gt%3B%2C%20T.%20K.%20et%20al.%20%282023%29.%20Direct%20cardiac%20reprogramming%3A%20A%20new%20technology%20for%20cardiac%20repair.%20%26lt%3Bi%26gt%3BJ%20Mol%20Cell%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B178%26lt%3B%5C%2Fi%26gt%3B%2C%2051%26%23x2013%3B58.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.yjmcc.2023.03.008%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.yjmcc.2023.03.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Direct%20cardiac%20reprogramming%3A%20A%20new%20technology%20for%20cardiac%20repair%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paige%20E.%22%2C%22lastName%22%3A%22Brlecic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clark%20A.%22%2C%22lastName%22%3A%22Bonham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megumi%22%2C%22lastName%22%3A%22Mathison%22%7D%5D%2C%22abstractNote%22%3A%22Cardiovascular%20disease%20is%20one%20of%20the%20leading%20causes%20of%20morbidity%20and%20mortality%20worldwide%2C%20with%20myocardial%20infarctions%20being%20amongst%20the%20deadliest%20manifestations.%20Reduced%20blood%20flow%20to%20the%20heart%20can%20result%20in%20the%20death%20of%20cardiac%20tissue%2C%20leaving%20affected%20patients%20susceptible%20to%20further%20complications%20and%20recurrent%20disease.%20Further%2C%20contemporary%20management%20typically%20involves%20a%20pharmacopeia%20to%20manage%20the%20metabolic%20conditions%20contributing%20to%20atherosclerotic%20and%20hypertensive%20heart%20disease%2C%20rather%20than%20regeneration%20of%20the%20damaged%20myocardium.%20With%20modern%20healthcare%20extending%20lifespan%2C%20a%20larger%20demographic%20will%20be%20at%20risk%20for%20heart%20disease%2C%20driving%20the%20need%20for%20novel%20therapeutics%20that%20surpass%20those%20currently%20available%20in%20efficacy.%20Transdifferentiation%20and%20cellular%20reprogramming%20have%20been%20looked%20to%20as%20potential%20methods%20for%20the%20treatment%20of%20diseases%20throughout%20the%20body.%20Specifically%20targeting%20the%20fibrotic%20cells%20in%20cardiac%20scar%20tissue%20as%20a%20source%20to%20be%20reprogrammed%20into%20induced%20cardiomyocytes%20remains%20an%20appealing%20option.%20This%20review%20aims%20to%20highlight%20the%20history%20of%20and%20advances%20in%20cardiac%20reprogramming%20and%20describe%20its%20translational%20potential%20as%20a%20treatment%20for%20cardiovascular%20disease.%22%2C%22date%22%3A%222023-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.yjmcc.2023.03.008%22%2C%22ISSN%22%3A%221095-8584%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BCTBZ4XB%22%2C%225WVJH2TN%22%5D%2C%22dateModified%22%3A%222023-06-08T13%3A53%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22ECR4BK4E%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Frankel%20et%20al.%22%2C%22parsedDate%22%3A%222023-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFrankel%2C%20W.%20C.%2C%20Sylvester%2C%20C.%20B.%2C%20Asokan%2C%20S.%20et%20al.%20%282023%29.%20Coronary%20artery%20bypass%20grafting%20at%20safety-net%20versus%20non%26%23x2013%3Bsafety-net%20hospitals.%20%26lt%3Bi%26gt%3BJTCVS%20Open%26lt%3B%5C%2Fi%26gt%3B%2C%20S2666273623000177.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjon.2023.01.008%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjon.2023.01.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Coronary%20artery%20bypass%20grafting%20at%20safety-net%20versus%20non%5Cu2013safety-net%20hospitals%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Frankel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20B.%22%2C%22lastName%22%3A%22Sylvester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sainath%22%2C%22lastName%22%3A%22Asokan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20T.%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%22%2C%22lastName%22%3A%22Zea-Vera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianzi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Wall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandeep%22%2C%22lastName%22%3A%22Markan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%20K.%22%2C%22lastName%22%3A%22Ghanta%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Jan%202023%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xjon.2023.01.008%22%2C%22ISSN%22%3A%2226662736%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2666273623000177%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%22BCTBZ4XB%22%2C%22VCK5HVUS%22%2C%22AFDZBLNB%22%2C%22JD5ZU4IS%22%5D%2C%22dateModified%22%3A%222023-03-14T14%3A57%3A08Z%22%7D%7D%2C%7B%22key%22%3A%226GAQEB2Q%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martinez-Vargas%20et%20al.%22%2C%22parsedDate%22%3A%222023-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMartinez-Vargas%2C%20M.%2C%20Cebula%2C%20A.%2C%20Brubaker%2C%20L.%20S.%20et%20al.%20%282023%29.%20A%20novel%20interaction%20between%20extracellular%20vimentin%20and%20fibrinogen%20in%20fibrin%20formation.%20%26lt%3Bi%26gt%3BThromb%20Res%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B221%26lt%3B%5C%2Fi%26gt%3B%2C%2097%26%23x2013%3B104.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.thromres.2022.11.028%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.thromres.2022.11.028%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20novel%20interaction%20between%20extracellular%20vimentin%20and%20fibrinogen%20in%20fibrin%20formation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Martinez-Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%22%2C%22lastName%22%3A%22Cebula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%20S.%22%2C%22lastName%22%3A%22Brubaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nitin%22%2C%22lastName%22%3A%22Seshadri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fong%20W.%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michele%22%2C%22lastName%22%3A%22Loor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Yee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rolando%20E.%22%2C%22lastName%22%3A%22Rumbaut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%20A.%22%2C%22lastName%22%3A%22Cruz%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Thrombosis%20is%20frequently%20manifested%20in%20critically%20ill%20patients%20with%20systemic%20inflammation%2C%20including%20sepsis%20and%20COVID-19.%20The%20coagulopathy%20in%20systemic%20inflammation%20is%20often%20associated%20with%20increased%20levels%20of%20fibrinogen%20and%20D-dimer.%20Because%20elevated%20levels%20of%20vimentin%20have%20been%20detected%20in%20sepsis%2C%20we%20sought%20to%20investigate%20the%20relationship%20between%20vimentin%20and%20the%20increased%20fibrin%20formation%20potential%20observed%20in%20these%20patients.%5CnMATERIALS%20AND%20METHODS%3A%20This%20hypothesis%20was%20examined%20by%20using%20recombinant%20human%20vimentin%2C%20anti-vimentin%20antibodies%2C%20plasma%20derived%20from%20healthy%20and%20critically%20ill%20patients%2C%20confocal%20microscopy%2C%20co-immunoprecipitation%20assays%2C%20and%20size%20exclusion%20chromatography.%5CnRESULTS%3A%20The%20level%20of%20vimentin%20in%20plasma%20derived%20from%20critically%20ill%20subjects%20with%20systemic%20inflammation%20was%20on%20average%20two-fold%20higher%20than%20that%20of%20healthy%20volunteers.%20We%20determined%20that%20vimentin%20directly%20interacts%20with%20fibrinogen%20and%20enhances%20fibrin%20formation.%20Anti-vimentin%20antibody%20effectively%20blocked%20fibrin%20formation%20ex%20vivo%20and%20caused%20changes%20in%20the%20fibrin%20structure%20in%20plasma.%20Additionally%2C%20confocal%20imaging%20demonstrated%20plasma%20vimentin%20enmeshed%20in%20the%20fibrin%20fibrils.%20Size%20exclusion%20chromatography%20column%20and%20co-immunoprecipitation%20assays%20demonstrated%20a%20direct%20interaction%20between%20extracellular%20vimentin%20and%20fibrinogen%20in%20plasma%20from%20critically%20ill%20patients%20but%20not%20in%20healthy%20plasma.%5CnCONCLUSIONS%3A%20The%20results%20describe%20that%20extracellular%20vimentin%20engages%20fibrinogen%20in%20fibrin%20formation.%20In%20addition%2C%20the%20data%20suggest%20that%20elevated%20levels%20of%20an%20apparent%20aberrant%20extracellular%20vimentin%20potentiate%20fibrin%20clot%20formation%20in%20critically%20ill%20patients%20with%20systemic%20inflammation%3B%20consistent%20with%20the%20notion%20that%20plasma%20vimentin%20contributes%20to%20the%20pathogenesis%20of%20thrombosis.%22%2C%22date%22%3A%22Jan%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.thromres.2022.11.028%22%2C%22ISSN%22%3A%221879-2472%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BCTBZ4XB%22%2C%22TXW6RMW4%22%5D%2C%22dateModified%22%3A%222023-01-06T17%3A11%3A31Z%22%7D%7D%2C%7B%22key%22%3A%223HGF86RB%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nowrouzi%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BNowrouzi%2C%20R.%2C%20Sylvester%2C%20C.%20B.%2C%20Treffalls%2C%20J.%20A.%20et%20al.%20%282022%29.%20Chronic%20kidney%20disease%2C%20risk%20of%20readmission%2C%20and%20progression%20to%20end-stage%20renal%20disease%20in%20519%2C387%20patients%20undergoing%20coronary%20artery%20bypass%20grafting.%20%26lt%3Bi%26gt%3BJTCVS%20Open%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%2C%20147%26%23x2013%3B157.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjon.2022.08.013%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjon.2022.08.013%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chronic%20kidney%20disease%2C%20risk%20of%20readmission%2C%20and%20progression%20to%20end-stage%20renal%20disease%20in%20519%2C387%20patients%20undergoing%20coronary%20artery%20bypass%20grafting%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Nowrouzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20B.%22%2C%22lastName%22%3A%22Sylvester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20A.%22%2C%22lastName%22%3A%22Treffalls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianzi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20R.%22%2C%22lastName%22%3A%22Moon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%20K.%22%2C%22lastName%22%3A%22Ghanta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20The%20association%20between%20chronic%20kidney%20disease%20and%20adverse%20outcomes%20after%20coronary%20artery%20bypass%20grafting%20is%20well%20established%3B%20in%20contrast%2C%20the%20association%20between%20chronic%20kidney%20disease%20and%20readmission%20has%20been%20less%20thoroughly%20investigated.%20We%20hypothesized%20that%20patients%20at%20higher%20chronic%20kidney%20disease%20stages%20have%20greater%20risk%20of%20readmission%2C%20poorer%20operative%20outcomes%2C%20and%20greater%20hospitalization%20cost.%5CnMETHODS%3A%20Using%20the%202016-2018%20Nationwide%20Readmissions%20Database%2C%20we%20identified%20519%2C387%20patients%20who%20underwent%20isolated%20coronary%20artery%20bypass%20grafting.%20Patients%20were%20stratified%20by%20chronic%20kidney%20disease%20stage%20based%20on%20International%20Classification%20of%20Diseases%2010th%20Revision%20classification.%20Multivariable%20logistic%20regression%20was%20used%20to%20assess%20risk%20factors%20for%20in-hospital%20mortality%20and%2090-day%20readmission.%5CnRESULTS%3A%20Hospital%20readmission%2C%20in-hospital%20mortality%2C%20and%20cost%20progressively%20increased%20with%20worsening%20chronic%20kidney%20disease%20stage%3B%20patients%20with%20end-stage%20renal%20disease%20had%20the%20highest%20in-hospital%20mortality%20rate%20%287.2%25%29%2C%20hospitalization%20costs%20%28%2459%2C616%29%20%28P%5Cu00a0%26lt%3B%5Cu00a0.001%29%2C%20and%2090-day%20readmission%20rate%20%2840%25%29%20%28P%5Cu00a0%26lt%3B%5Cu00a0.001%29.%20Chronic%20kidney%20disease%20stage%20greater%20than%203%20was%20associated%20with%20in-hospital%20mortality%20%28odds%20ratio%2C%201.56%2C%2095%25%20confidence%20interval%2C%201.40-1.73%3B%20P%5Cu00a0%26lt%3B%5Cu00a0.001%29%20and%2090-day%20readmission%20%28odds%20ratio%2C%201.66%2C%2095%25%20confidence%20interval%2C%201.56-1.76%3B%20P%5Cu00a0%26lt%3B%5Cu00a0.001%29.%20At%2030%5Cu00a0days%20after%20discharge%2C%20new-onset%20dialysis%20dependence%20was%20more%20frequent%20in%20patients%20readmitted%20with%20chronic%20kidney%20disease%204%20to%205%20%288.9%25%3B%20n%5Cu00a0%3D%5Cu00a01495%29%20than%20in%20patients%20with%20chronic%20kidney%20disease%201%20to%203%20%281.4%25%3B%20n%5Cu00a0%3D%5Cu00a08623%29%20and%20patients%20without%20chronic%20kidney%20disease%20%280.3%25%3B%20n%5Cu00a0%3D%5Cu00a038%2C885%29.%20At%2090%5Cu00a0days%20after%20discharge%2C%20dialysis%20dependence%20increased%20to%2011.1%25%20%28n%5Cu00a0%3D%5Cu00a01916%29%20in%20readmitted%20patients%20with%20chronic%20kidney%20disease%204%20to%205%20but%20remained%20stable%20for%20patients%20with%20chronic%20kidney%20disease%201%20to%203%20%281.4%25%3B%20n%5Cu00a0%3D%5Cu00a010%2C907%29%20and%20patients%20without%20chronic%20kidney%20disease%20%280.3%25%3B%20n%5Cu00a0%3D%5Cu00a050%2C200%29.%5CnCONCLUSIONS%3A%20Chronic%20kidney%20disease%20stage%20is%20strongly%20associated%20with%20mortality%2C%20new-onset%20dialysis%20dependence%2C%20readmission%2C%20and%20higher%20cost%20after%20coronary%20artery%20bypass%20grafting.%20Patients%20with%20chronic%20kidney%20disease%204%20and%205%20and%20patients%20with%20end-stage%20renal%20disease%20are%20readmitted%20at%20the%20highest%20rates.%20Although%20further%20research%20is%20needed%2C%20a%20targeted%20approach%20may%20reduce%20costly%20readmissions%20and%20improve%20outcomes%20after%20coronary%20artery%20bypass%20grafting%20in%20patients%20with%20chronic%20kidney%20disease.%22%2C%22date%22%3A%22Dec%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xjon.2022.08.013%22%2C%22ISSN%22%3A%222666-2736%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%22BCTBZ4XB%22%2C%22VCK5HVUS%22%2C%22AFDZBLNB%22%2C%22VKADJP5D%22%2C%22TXW6RMW4%22%5D%2C%22dateModified%22%3A%222023-01-06T17%3A12%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22JUBJ4ASQ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Williams%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWilliams%2C%20A.%20M.%2C%20Shah%2C%20N.%20P.%2C%20%26lt%3Bstrong%26gt%3BRosengart%26lt%3B%5C%2Fstrong%26gt%3B%2C%20T.%20et%20al.%20%282022%29.%20Emerging%20role%20of%20positron%20emission%20tomography%20%28PET%29%20imaging%20in%20cardiac%20surgery.%20%26lt%3Bi%26gt%3BJ%20Card%20Surg%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjocs.16992%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjocs.16992%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Emerging%20role%20of%20positron%20emission%20tomography%20%28PET%29%20imaging%20in%20cardiac%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20M.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nishant%20P.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20J.%22%2C%22lastName%22%3A%22Povsic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20R.%22%2C%22lastName%22%3A%22Williams%22%7D%5D%2C%22abstractNote%22%3A%22Historically%2C%20structural%20and%20anatomical%20imaging%20has%20been%20the%20mainstay%20in%20the%20diagnosis%20and%20management%20of%20cardiovascular%20diseases.%20In%20recent%20years%20there%20has%20been%20a%20shift%20toward%20increased%20use%20of%20functional%20imaging%20studies%2C%20including%20positron%20emission%20tomography%20%28PET%29.%20PET%20is%20a%20noninvasive%20nuclear%20medicine-imaging%20technique%20that%20uses%20radiotracers%20to%20generate%20images%20of%20a%20radionucleotide%20distribution%20by%20detecting%20the%20physiologic%20substrates%20that%20emit%20positron%20radionuclides.%20This%20article%20will%20focus%20on%20the%20applications%20of%20PET%20imaging%20for%20the%20cardiac%20surgeon%20and%20highlight%20the%20collaborative%20nature%20of%20using%20PET%20imaging%20for%20the%20management%20of%20complex%20heart%20disease.%20We%20present%20cases%20that%20demonstrate%20the%20value%20of%20using%20PET%20imaging%20in%20the%20diagnosis%20of%20coronary%20artery%20disease%20and%20management%20of%20complex%20endocarditis%2C%20and%20in%20targeted%20cardiovascular%20therapies.%22%2C%22date%22%3A%22Nov%2008%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fjocs.16992%22%2C%22ISSN%22%3A%221540-8191%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BCTBZ4XB%22%2C%22QF52JASW%22%5D%2C%22dateModified%22%3A%222022-12-01T19%3A17%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22ANRNN69N%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ryan%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRyan%2C%20C.%20T.%2C%20Zeng%2C%20Z.%2C%20Chatterjee%2C%20S.%20et%20al.%20%282022%29.%20Machine%20learning%20for%20dynamic%20and%20early%20prediction%20of%20acute%20kidney%20injury%20after%20cardiac%20surgery.%20%26lt%3Bi%26gt%3BJ%20Thorac%20Cardiovasc%20Surg%26lt%3B%5C%2Fi%26gt%3B%2C%20S0022-5223%2822%2901030%26%23x2013%3B3.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jtcvs.2022.09.045%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jtcvs.2022.09.045%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Machine%20learning%20for%20dynamic%20and%20early%20prediction%20of%20acute%20kidney%20injury%20after%20cardiac%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20T.%22%2C%22lastName%22%3A%22Ryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zijian%22%2C%22lastName%22%3A%22Zeng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhasis%22%2C%22lastName%22%3A%22Chatterjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Wall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20R.%22%2C%22lastName%22%3A%22Moon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meng%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%20K.%22%2C%22lastName%22%3A%22Ghanta%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Acute%20kidney%20injury%20after%20cardiac%20surgery%20increases%20morbidity%20and%20mortality.%20Diagnosis%20relies%20on%20oliguria%20or%20increased%20serum%20creatinine%2C%20which%20develop%2048%20to%2072%5Cu00a0hours%20after%20injury.%20We%20hypothesized%20machine%20learning%20incorporating%20preoperative%2C%20operative%2C%20and%20intensive%20care%20unit%20data%20could%20dynamically%20predict%20acute%20kidney%20injury%20before%20conventional%20identification.%5CnMETHODS%3A%20Cardiac%20surgery%20patients%20at%20a%20tertiary%20hospital%20%282008-2019%29%20were%20identified%20using%20electronic%20medical%20records%20in%20the%20Medical%20Information%20Mart%20for%20Intensive%20Care%20IV%20database.%20Preoperative%20and%20intraoperative%20parameters%20included%20demographics%2C%20Charlson%20Comorbidity%20subcategories%2C%20and%20operative%20details.%20Intensive%20care%20unit%20data%20included%20hemodynamics%2C%20medications%2C%20fluid%20intake%5C%2Foutput%2C%20and%20laboratory%20results.%20Kidney%20Disease%3A%20Improving%20Global%20Outcomes%20creatinine%20criteria%20were%20used%20for%20acute%20kidney%20injury%20diagnosis.%20An%20ensemble%20machine%20learning%20model%20was%20trained%20for%20hourly%20predictions%20of%20future%20acute%20kidney%20injury%20within%2048%5Cu00a0hours.%20Performance%20was%20evaluated%20by%20area%20under%20the%20receiver%20operating%20characteristic%20curve%20and%20balanced%20accuracy.%5CnRESULTS%3A%20Within%20the%20cohort%20%28n%5Cu00a0%3D%5Cu00a04267%29%2C%20there%20were%20approximately%207%20million%20data%20points.%20Median%20baseline%20creatinine%20was%201.0%5Cu00a0g%5C%2FdL%20%28interquartile%20range%2C%200.8-1.2%29%2C%20with%2017%25%20%28735%5C%2F4267%29%20of%20patients%20having%20chronic%20kidney%20disease.%20Postoperative%20stage%201%20acute%20kidney%20injury%20occurred%20in%2050%25%20%282129%5C%2F4267%29%2C%20stage%202%20occurred%20in%208%25%20%28324%5C%2F4267%29%2C%20and%20stage%203%20occurred%20in%204%25%20%28183%5C%2F4267%29.%20For%20hourly%20prediction%20of%20any%20acute%20kidney%20injury%20over%20the%20next%2048%5Cu00a0hours%2C%20area%20under%20the%20receiver%20operating%20characteristic%20curve%20was%200.82%2C%20and%20balanced%20accuracy%20was%2075%25.%20For%20hourly%20prediction%20of%20stage%202%20or%20greater%20acute%20kidney%20injury%20over%20the%20next%2048%5Cu00a0hours%2C%20area%20under%20the%20receiver%20operating%20characteristic%20curve%20was%200.95%20and%20balanced%20accuracy%20was%2086%25.%20The%20model%20predicted%20acute%20kidney%20injury%20before%20clinical%20detection%20in%2089%25%20of%20cases.%5CnCONCLUSIONS%3A%20Ensemble%20machine%20learning%20models%20using%20electronic%20medical%20records%20data%20can%20dynamically%20predict%20acute%20kidney%20injury%20risk%20after%20cardiac%20surgery.%20Continuous%20postoperative%20risk%20assessment%20could%20facilitate%20interventions%20to%20limit%20or%20prevent%20renal%20injury.%22%2C%22date%22%3A%22Oct%2004%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jtcvs.2022.09.045%22%2C%22ISSN%22%3A%221097-685X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%22BCTBZ4XB%22%2C%22VCK5HVUS%22%2C%22AFDZBLNB%22%2C%22VKADJP5D%22%2C%22QF52JASW%22%5D%2C%22dateModified%22%3A%222022-12-01T19%3A18%3A25Z%22%7D%7D%2C%7B%22key%22%3A%227LIQZA36%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brlecic%20and%20Rosengart%22%2C%22parsedDate%22%3A%222022-09-13%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrlecic%2C%20P.%20E.%20and%20%26lt%3Bstrong%26gt%3BRosengart%26lt%3B%5C%2Fstrong%26gt%3B%2C%20T.%20K.%20%282022%29.%20Commentary%3A%20Myocardial%20relaxation%20matters.%20%26lt%3Bi%26gt%3BJ%20Thorac%20Cardiovasc%20Surg%26lt%3B%5C%2Fi%26gt%3B%2C%20S0022-5223%2822%2900949%26%23x2013%3B7.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jtcvs.2022.09.008%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jtcvs.2022.09.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Commentary%3A%20Myocardial%20relaxation%20matters%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paige%20E.%22%2C%22lastName%22%3A%22Brlecic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20K.%22%2C%22lastName%22%3A%22Rosengart%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Sept%2013%2C%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jtcvs.2022.09.008%22%2C%22ISSN%22%3A%221097-685X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BCTBZ4XB%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A24%3A02Z%22%7D%7D%5D%7D
Ali, A., Gray, Z., Loor, G. ve diğerleri (2024). Daha Önce Kalp Ameliyatı Geçiren Hastalarda Soğuk Fibrilasyonlu Kardiyak Arrest Tekniği Kullanılarak Yapılan Minimal İnvaziv Mitral Kapak Cerrahisi. Teksas Kalp Enstitüsü Dergisi 51, E238167. https://doi.org/10.14503/THIJ-23-8167.
Brlecic, PE, Whitlock, RS, Zhang, Q. ve diğerleri. (2023). Ulusal Sağlık Enstitüsü finansmanının cerrahi departmanlarına dağıtımı daralıyor. J Cerrahi Res 289, 8-15. https://doi.org/10.1016/j.jss.2023.03.023.
Sylvester, CB, Ryan, CT, Frankel, WC ve diğerleri. (2023). Cerrahi aort kapak değişimi sonrası yeniden yatışlar: protez tipinin etkisi. J Cerrahi Res 287, 124-133. https://doi.org/10.1016/j.jss.2023.01.007.
Brlecic, PE, Bonham, CA, RosengartTK ve ark. (2023). Doğrudan kardiyak yeniden programlama: Kalp onarımı için yeni bir teknoloji. J Mol Hücre Kardiol 178, 51-58. https://doi.org/10.1016/j.yjmcc.2023.03.008.
Frankel, WC, Sylvester, CB, Asokan, S. ve diğerleri. (2023). Güvenlik ağı olmayan hastanelere karşı güvenlik ağı olan hastanelerde koroner arter baypas greftlemesi. JTCVS Açık, S2666273623000177. https://doi.org/10.1016/j.xjon.2023.01.008.
Martinez-Vargas, M., Cebula, A., Brubaker, LS ve diğerleri. (2023). Fibrin oluşumunda hücre dışı vimentin ve fibrinojen arasında yeni bir etkileşim. Tromb Çözünürlüğü 221, 97-104. https://doi.org/10.1016/j.thromres.2022.11.028.
Nowrouzi, R., Sylvester, CB, Treffalls, JA ve diğerleri. (2022). Koroner arter bypass ameliyatı geçiren 519,387 hastada kronik böbrek hastalığı, yeniden kabul riski ve son dönem böbrek hastalığına ilerleme. JTCVS Açık 12, 147-157. https://doi.org/10.1016/j.xjon.2022.08.013.
Williams, AM, Şah, NP, Rosengart, T. ve ark. (2022). Kalp cerrahisinde pozitron emisyon tomografisi (PET) görüntülemenin ortaya çıkan rolü. J Kart Cerrahisi. https://doi.org/10.1111/jocs.16992.
Ryan, CT, Zeng, Z., Chatterjee, S. ve diğerleri. (2022). Kalp ameliyatı sonrası akut böbrek hasarının dinamik ve erken tahmini için makine öğrenimi. J Torak Kardiyovasküler Cerrahi, S0022-5223(22)01030–3. https://doi.org/10.1016/j.jtcvs.2022.09.045.
Brlecic, PE ve Rosengart, TK (2022). Yorum: Miyokardiyal gevşeme önemlidir. J Torak Kardiyovasküler Cerrahi, S0022-5223(22)00949–7. https://doi.org/10.1016/j.jtcvs.2022.09.008.
PHP Kod Parçacıkları Powered By: XYZScripts.com